Sign up now with your company or organization email and enjoy a
1-week free trial!
Contract Details
| Title |
Conclusion of a Contract for the Delivery of Drugs for the Treatment of Coagulation Disorders in the Period from 1.1.2021 to Max As of December 31, 2022 Germany |
|||
|---|---|---|---|---|
You can sign up and unlock it for freeAccess to Public and Private Sector Business Opportunities for 200+ Countries |
||||
| Country | ||||
| Language | English | |||
| Organization | ||||
| Published Date | 06.02.2024 | |||
| Awarded Date | 22.12.2020 | |||
| Overview | Contract Award's Details : Conclusion of a Contract for the Delivery of Drugs for the Treatment of Coagulation Disorders in the Period from 1.1.2021 to Max As of December 31, 2022 SPECTRUMK GMBH Conclusion of a Contract for the Delivery of Drugs for the Treatment of Coagulation Disorders in the Period from 1.1.2021 to Max As of December 31, 2022 Document Type: Voluntary ex ante transparency notice Title: Conclusion of a contract for the delivery of drugs for the treatment of coagulation disorders in the period from 1.1.2021 to max. as of December 31, 2022 Reference Number: 2020 / S 244-604514 Contract Type: Supplies Estimated Value: 1.00 - EUR Description: The health insurance companies intend to conclude a discount agreement in accordance with Section 130a, Paragraph 8 of Book V of the Social Code for the products listed below. This discount agreement includes the reimbursement of pharmaceuticals and supplies for the insured. The contract period is 24 months, starting on January 1, 2021. The contract can be extended once for a maximum of 6 months. - Advate, Octocog alfa, - Feiba NF, human plasma proteins with factor VIII inhibitor bypass activity, - Immunate, blood coagulation factor VIII (human) | Von Willebrand Factor, - Immunine, blood coagulation factor IX (human), - Immuseven, blood coagulation factor VII (human), - Recombinate, Octocog alfa, - Rixubis, Nonacog gamma, - Veyvondi, Vonicog alfa. 33600000 - Pharmaceutical products Authority Type: Other Type of Procedure: Negotiated witho ... Germany Contract value : 1.00 EUR Contractors : TAKEDA MANUFA C TSURIN G A G WIEN, BAAL TAIN OACHION S GMBH WIEN, TAKEDA GMBH 09/12/2020 23/12/2020 See in details 76965587 23/12/2020 SPECTRUMK GMBH Address : Town: Food NUTS code: DE - GERMANY www.spectrumk.de open-house@spectrumk.de Germany Germany Contract Awards Germany 09/12/2020 See in details 1.00 EUR | |||
| NAICS | ||||
| CPVS | ||||
| UNSPSC |
-
|
|||
| Regions | ||||
| Sectors | ||||
| Contractor | ||||
| Contract Value |
1.00 EUR
|
URL | ||
| Share | ||||
Germany
| Title |
|---|
Conclusion of a Contract for the Delivery of Drugs for the Treatment of Coagulation Disorders in the Period from 1.1.2021 to Max As of December 31, 2022 Germany |
| Country |
| Language |
| English |
| Organization |
| Published Date |
| 06.02.2024 |
| Awarded Date |
| 22.12.2020 |
| Overview |
| Contract Award's Details : Conclusion of a Contract for the Delivery of Drugs for the Treatment of Coagulation Disorders in the Period from 1.1.2021 to Max As of December 31, 2022 SPECTRUMK GMBH Conclusion of a Contract for the Delivery of Drugs for the Treatment of Coagulation Disorders in the Period from 1.1.2021 to Max As of December 31, 2022 Document Type: Voluntary ex ante transparency notice Title: Conclusion of a contract for the delivery of drugs for the treatment of coagulation disorders in the period from 1.1.2021 to max. as of December 31, 2022 Reference Number: 2020 / S 244-604514 Contract Type: Supplies Estimated Value: 1.00 - EUR Description: The health insurance companies intend to conclude a discount agreement in accordance with Section 130a, Paragraph 8 of Book V of the Social Code for the products listed below. This discount agreement includes the reimbursement of pharmaceuticals and supplies for the insured. The contract period is 24 months, starting on January 1, 2021. The contract can be extended once for a maximum of 6 months. - Advate, Octocog alfa, - Feiba NF, human plasma proteins with factor VIII inhibitor bypass activity, - Immunate, blood coagulation factor VIII (human) | Von Willebrand Factor, - Immunine, blood coagulation factor IX (human), - Immuseven, blood coagulation factor VII (human), - Recombinate, Octocog alfa, - Rixubis, Nonacog gamma, - Veyvondi, Vonicog alfa. 33600000 - Pharmaceutical products Authority Type: Other Type of Procedure: Negotiated witho ... Germany Contract value : 1.00 EUR Contractors : TAKEDA MANUFA C TSURIN G A G WIEN, BAAL TAIN OACHION S GMBH WIEN, TAKEDA GMBH 09/12/2020 23/12/2020 See in details 76965587 23/12/2020 SPECTRUMK GMBH Address : Town: Food NUTS code: DE - GERMANY www.spectrumk.de open-house@spectrumk.de Germany Germany Contract Awards Germany 09/12/2020 See in details 1.00 EUR |
| NAICS |
| Other Direct Insurance (except Life Bolt Turned Product and Screw Direct Insurance (except Life Book Newspaper Direct Life Book Sporting Goods Machine Shops; Turned Product; and Screw |
| CPVS |
| Nuts Sections Food, beverage and tobacco-processing machinery Book ends Food, beverages, tobacco and related products |
| UNSPSC |
| - |
| Regions |
| Europe Western Europe |
| Sectors |
| Building Automobiles and Auto Parts Supply Banking-Finance-Insurance Cement and Asbestos Products Defence and Security Construction Energy-Power and Electrical Computer Hardwares and Consumables Pharmaceuticals Aviation Building Material Construction Materials |
| Contractor |
| Contract Value |
|
1.00 EUR
|
| URL |
|
|
| Share |
To be notified
when a tender matching your filter is
published
To Follow
Tenders
Add New Tender Alert
To Follow
Contracts
Add New Contract Alert
To Follow
Fairs
Add New Fair Alert
Similar Contracts